Научная статья на тему 'Bi-Ning capsule on experimental study on hprt gene in patients with gouty arthritis'

Bi-Ning capsule on experimental study on hprt gene in patients with gouty arthritis Текст научной статьи по специальности «Клиническая медицина»

CC BY
46
7
i Надоели баннеры? Вы всегда можете отключить рекламу.
i Надоели баннеры? Вы всегда можете отключить рекламу.
iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
i Надоели баннеры? Вы всегда можете отключить рекламу.

Текст научной работы на тему «Bi-Ning capsule on experimental study on hprt gene in patients with gouty arthritis»

[02] Psychiatry Branch of the Chinese Medical Association. Chinese classification and diagnostic criteria of mental disorders [S]. Third edition (CCMD-3), Jinan: Shandong Science and Technology Press,2001:87-88

[03]International disease classification and diagnostic criteria-10Edition. People's Health Publishing House [M], 2008,07, Second Edition: 179

[04] Acupoint Naming and Location.Standards Press of China [M], 2006,12:45

[05]XuJuanLi, Deqiang LI. Depression spectral analysis of heart rate variability [J]. Zhejiang Medicine, 2007,29 (9) :916-918

[06]KoenG,Van der Kooy.Differences in heart rate variability between depressedand non-depress elderly[J]. Int J Geriatr Psychiatry,2006, 21:147- 150

[07] Yijuan Zhong, En Huangfu, Jiatong Wang. Anxiety disorder spectral analysis of heart rate variability study [J]. Chinese Journal of Behavioral Medical Science, 2004,13(3):294-295

[08] Honglei Yin. Depression, anxiety disorder symptoms, neuroendocrine and autonomic function correlation. Southern Medical University, master's degree thesis .2011:30-33

[09] Qian Zhang, Tong Luan, Aiqin Wu, etc. Different patients with anxiety and depression syndromes heart rate variability characteristics [J]. Journal of Medical Research, 2008,37 (9) :77-80

BI-Ning capsule on experimental study on HPRT gene in patients with gouty

arthritis

1 2 3 2 4 2

Tongying Su Guanxia Jintang Bo Wang Fuqing Yang Meng Jie

(1. first affiliated hospital of Harbin of HeilongjiangUniversity of traditional Chinese medicine Harbin,China;2. HeilongjiangUniversity of traditional Chinese medicine Harbin,China;;3. Hospital of traditional Chinese medicine in Harbin Harbin,China;4. RaoheCountyHospital in Heilongjiang

province,Raohe, China.)

Abstracts:Objective: This researchobserve the effect on patients of HPRT (hypoxanthine-guanine phosphoribosyltransferase) gene with 78 cases of acute goutyarthritis by bi-Ning capsule.Methods: 78 cases of acute gouty arthritis by random principles are divided into bi-Ning capsule group and the control group, observation of serum HPRTmRNA levels in both groups before and after treatment. Results: serum HPRTmRNA-expression is better than a control group of the pilot group. Conclusion: BI-Ning capsule is superior to the western medicine in the therapeutic effect on acute gouty arthritis, and it improves the expressing levels of HPRTmRNA in patients with acute gouty arthritis.

Key words: acute gouty arthritis; bi-Ning capsule; HPRTmRNA.

Gout and hyperuricemia is the disease of multifactorial inheritance.The serum uric acid rise is the important biochemical basisof gout.The exoterica of the scanty key enzyme inpurine metabolism process is main causes of hyperuricemia ,which through our topics group research further confirmed.HPRT gene is purine metabolism remedy synthesis way of key enzyme, HPRT gene defects can led to its activity reduced and can make bird purine nucleotide and times yellow purine nucleotide reduced, that eventually led to its end late product uric acid increased. The report is as follows:

1. Clinical data 1.1 Source of case

In this research 78 gouty arthritis patients hail from the first affiliated hospital of Heilongjiang University of traditional Chinese medicine Rheumatology from 2007 to 2011,which male in 71 cases, women's 7. Normal human peripheral blood samples, taken from our 5 healthy volunteers.

Model group is the blood sample of 78 gout patientsbefore treatment.On a random basis is divided into Group (bi-Ning capsule group) and control group (Western medicine colchicine groups), two groups of patients generally by statistical analysis, the difference was not significant meaning (P>0.05), and comparability.

1.2Diagnosis standard:

Western diagnosis standard: reference 7th edition of internal medicine under[1] ("high uric acid blood syndrome and gout" in the of Western diagnosis standard and the Meng Zhaoheng authored of in the acute gout sexual arthritis of diagnosis standard [2]

1.2.2 The Chinese medicine diagnosis standard: according to early research conclusions and the bi Ning soup of group party principles, basis Guiding principle of clinical research on new drugs of traditional Chinese Medicine under [3] in the gout of TCM card type diagnosis standard, the enrolled cases meet a criterion of damp-heat syndrome .

2. Research technique

2.1 Treatment drug: BI Ning capsule main ingredient: desmodium 15g, fructus corni 20 g, semen plantaginis12g, radix clematidis 15g, gentiana 15g, and Z Rhizome Dioscoreae Hypoglaucae mosses 15g, and smilax glabra 15g, forsythia 10g, and ligusticum wallichii 12g, caulis lonicerae 20g, radix 10g,, specifications for 0.5G/bag, each bag containing pharmacognostic 0.3mg, every time 4 capsules, tid,po.

2.2 Controlled drug: colchicine tablets (pharmaceutical limited liability company of Xishuangbanna), 2 tablets after meals. Two groups of patients were continuously taking them 7 days for a course, statistical effect after the two treatments, medication-ban serving a high purine diet, pungent irritants, drinking and so on.

2.3 Experimental groups: normal set of 5 cases of normal human peripheral blood samples; Model groups for the gout patients before the treatment of 78 cases of blood samples; after taking two courses are divided into group and control group, pilot group for bi-Ning capsule in the treatment of traditional Chinese medicine group, a total of 42 cases in the control group for Western medicine colchicine groups, a total of 36 cases.

2.4 Experimental reagents: Main reagents for PCR primers for P--actin length 432bp, HPRT length 476bp. Trizol RNAIsolation Kit, TaqDNA, and reverse transcriptase polymerase detection, UV gel Imaging System. 2.4 observing targets: serum HPRTmRNA levels

2.5 Experimental steps: expression by RT-PCR method for detection of serum HPRTmRNA in patients with gout, calculate total RNA extraction, RNA reverse transcriptase double-stranded cDNA, using DNA polymerase chain reaction (PCR) amplification of cDNA, amplification products in 1.5% in agarose gel electrophoresis, electrophoresis in observed and photographed under UV light after, VILBER-LOURMAT imaging system used for analysis, respectively measuring HPRTmRNA, Beta-actin electrophoretic band optical density and total area of expression level as representatives of HPRT/p--actin ratio HPRTmRNA

2.6 Statistic processThe statistical description use means±standard deviation ( x ±S) ,and apply to STATA 12.0 programme.

3. Result

3.1 Serum HPRTmRNA in patients with gouty arthritis electrophoretic band brightness variation (see Figure 1, Figure 2). In Figure 1, 2 shows, agarose electrophoresis gel 653 observation under UV lights are visible on BP fragment, but various groups of electrophoresis with obvious differences in brightness. Group of P--actin electrophoresis with brightness, amplification of fragments are 432bp.

Above results indicates that, , two group gout sexual arthritis patients treatment Qian model group HPRTmRNA expression obviously declined (P<0.01) and compared to normal group.Two group HPRTmRNA expression obviously rise after treatment (P<0.01); normal group and against group and ramped patients compared to HPRTmRNA expression has obviously differences (P<0.01); Chinese medicine bi Ning capsule group and against group compared to, serum

HPRTmRNA expression is obviously rise (P<0.01). Gene point mutation, and insertion deletionolymorphism may result to decrease the enzyme activity and increased uric acid synthesis, or only present as Lasch-Nylan syndrome characterized by high uric acid or gout. Bi-Ning capsule can greatly improve the expression of the HPRTmRNA reduce serum uric acid withgout patients,which is root in treating this disease.

2000BP

57» 250BP-100BP-

Figure 1: Beta-actin M:Ladder marker;1 mRNA by RT-PCR gel electrophoresis products: normal; 2: model group (prior to treatment); 3: pilot group (BI-Ning capsule); 4: control group (colchicine).

2000b

№ 250bp lOObp

Figure 2: HPRTmRNA m RT-PCR electrophoresis products: is Ladder marker;1: normal; 2: model group (prior to treatment); 3: pilot group (BI-Ning capsule); 4: control group (colchicine).

3.2 Table 1HPRTmRNA electrophoresis products of change comparison ( x ±S)_

Group Case HPRT/ß-actin

normal group 5 0.8213±0.0385

Model group 78 0.1826±0.0355

Experimentalgroup 42 0.8057±0.0422*

control group 36 0.5835±0.0343*

4. Discussion

Gout and hyperuricemia is the disease of multifactorial inheritance.The exoterica of the scanty key enzyme inpurine metabolism process is main causes of hyperuricemia which phosphate ribose Coke phosphate synthesis enzymeand phosphate ribose Coke phosphate amino transfer enzyme, and times yellow purine phosphate ribose transfer enzyme defects belonging to x with sexual genetic, yellow purine oxidation enzyme activity increased may for more gene genetic, our research mainly study related gene of uric acid generated increased. HPRT is key enzyme in the purine metabolism remedy synthesis way, which has became gene mutations mechanism and repair mechanism ideal of research target points in the recently research[4].HPRT gene defects led to its activity reduced,which can make bird purine and times yellow purine changes for bird purine nucleotide and times yellow purine nucleotide reduced, and two species purine is incapable ofusing synthesis nucleic acid and eventually led to its final product( uric acid )increased. The study from the molecular level to further clarify the pathogenesis of hyperuricemia and gout. for early prevention and treatment of the disease and the development of new drug targets to provide the scientific basis and rationale.

Tongying think the substance of gout isthe malfunction of spleen and kidney and the intrinsic heat of Zang-Fu .Gout with hot and humid cloud of phlegm drugs as standard [5]Gout patients are damp heat constitution, addicted to drink ,like greasy and surfeit flavour.That induced Zang-Fu organs dysfunction, ascending the clear and descending the turbid has no right to, and accumulation

of damp-heat syndrome delays in blood, stagnates in the condyles, and due to exogenous pathogenic wind attacks meridians, Qi and blood poor run, phlegm-damp in between the bones and tendons, muscles [6]. Lysimachia, Plantago as the principal drugs, enable promoting diuresis for stranguria, dehumidify , relieve internal heat or fever, detumescence . Its sweet and light permeability, and salt to soft, slightly cold heat, Tom Lee sanjiao, longer than the wet, wet treatment of bi syndrome what is preferred.Radix clematidis is ministerial drug, drugs diaphoresis, pungent warm, passing 12 meridians, both expelling wind and removing damness,collaterals and take away the pain, while distribution of Gentiana, smilax glabra, Z Rhizome Dioscoreae Hypoglaucae Moss, rhizoma et radix notopterygii associate drugs, removing a total of rheumatism, clearing hot and humid, bi Tong, clear Interior heat. According to modern pharmacological research on decoction of Clematis have some immune suppression [7] edible Tulip colchicine-like role, also has significant inhibition of angiogenesis activity and role of synovial tissue, can be used to eliminate inflammation of the joints [8-9] Psyllium can inhibit the synthesis of uric acid, dihydro chlorothiazide lysimachia similar enhancing effect of ureteral peristalsis and increases urine flow, and two effects is parallelism, Z Rhizome Dioscoreae Hypoglaucae Moss. Gentiana, smilax glabra have diuretic effect, lead to blood uric acid decrease, and remedygouty arthritis[10-11]

With the change of diet structure, we'll see the rate of gout arthritis among young and middle-aged people rising. Western medicine treatment have liver and kidney damage. Chinese medicine in the treatment of this disease have a great deal of progress, summed up many proven treatments and simple formula, the study of single herbs are also more. In the literature, it is rarely and superficial understanding to studies on the mechanism.Specific targets are not clear, no basis for experimental study. In addition, disease norms inconsistent, unreasonable, are problems of research design, these are further areas that need improvement and effort. References

[I] The scientific editor in Chief/Lu zaiying-7 editions-Beijing: people's medical publishing house. 2008,1.

.[2] Meng Zhaoheng authoring. gout, Beijing: PekingUnionMedicalUniversity, BeijingMedicalUniversity jointly published 1998.

[3] People's Republic of China Ministry of health released. guideline for clinical research of new traditional Chinese medicine. 1995.

[4] Liu Bo, Liang Qingmo. factors affecting rates of detection of mutations of HPRT gene [J]. modern medicine and health 2012,28 (1): 87-88.

[5] Zhou Qinghua, Sun Suping. From dark drug treating gout experience [J]. 2010,1 of traditional Chinese medicine (1). 146.

[6] xiaoxiayi, Wang Yifei. Stage with combination of TCM and Western medicine comprehensive prevention programmes impact on quality of life in patients with gout [J]. Chinese Journal of integrated traditional and Western medicine 2012,32 (5).

[7] Wu Qing, Ju Xuepeng, shut branches. Clematis decoction on mice with adjuvant-induced arthritis study on effect and mechanism of [J]. Pharmacology and clinical 2011,27 (1): 68-70.

[8] Shen Jin autumn. pharmacological study and clinical application of edible Tulip compilation [J]. Journal of practical traditional Chinese internal medicine 2008,22 (10).

[9] Xie Aidi. experience of xiezhuo huoxue method in treating gout [J]. pharmaceutical industry information, 2005,2 (24).

[10] Zheng Xuan, Sun Hong. psyllium on Wistar rats with high uric acid uric acid reduction mechanism [J]. 2010,41 of traditional Chinese medicine of Fujian (6) 52-53.

[II] Gao xuemin. clinical pharmacy. Hebei Science and technology press. 2005.

i Надоели баннеры? Вы всегда можете отключить рекламу.